Latest Investment News

Marimaca Copper has successfully raised A$80 million through a strongly supported placement, positioning the company to advance exploration and development at its flagship Chilean copper projects.

Pathkey.AI’s TrialKey platform has demonstrated a 73% alignment with actual biotech trial outcomes, showing an average hypothetical share price gain of 76%, underscoring AI’s growing role in clinical trial prediction and biotech investing.

Resolute Mining has announced a significant 28% increase in the gold resource at its Doropo project in Côte d’Ivoire, boosting the total to 4.4 million ounces and setting the stage for an extended mine life beyond the initial plan.

Prophecy International flags higher churn and softer US sales for its Snare product, prompting a conservative FY2026 outlook and $3.2 million in annual cost savings.

QuickFee Limited has divested its US Pay Now payments business for US$26.35 million while keeping its US Finance operations and loan book, withdrawing FY26 earnings guidance amid ongoing tax and transaction cost assessments.

Critical Resources Limited has completed due diligence on the Cap Burn Gold-Antimony project in New Zealand and is moving forward with acquisition and exploration plans, aiming to start drilling by October or November 2025.

Finder Energy is fast-tracking its Kuda Tasi and Jahal development with advanced engineering and critical FPSO evaluations, aiming for a Final Investment Decision in 2026. This acceleration seeks to reduce risks and optimize costs ahead of production.

Ardea Resources updates on the Kalgoorlie Nickel Project’s Goongarrie Hub, announcing a delay in the Definitive Feasibility Study completion to early 2026 while highlighting ongoing technical advances and strong JV collaboration.

Delorean Corporation has locked in a long-term biomethane supply agreement with Origin Energy, underpinning its SA1 Salisbury bioenergy project with up to $40 million in revenue over 10 years.

Platinum Asset Management reported significant net outflows in August 2025, reducing its funds under management to $7.6 billion. The decline was influenced by investor withdrawals and a special dividend tied to a corporate scheme.

Harvey Norman Holdings Limited has responded to ASX inquiries confirming its FY25 earnings aligned with market expectations, despite the absence of formal guidance and complexities in analyst forecasting.

The Alternative Investment Trust (AIQ) has extended its on-market buy-back of up to 10% of issued units, signaling continued capital management efforts amid steady market conditions.